ABL Diagnostics entered a commercialization agreement with Anatech Instruments to market its DeepChek and UltraGene molecular assay lines in South Africa. Anatech will offer DeepChek’s sequencing assays nonexclusively and UltraGene’s viral load PCR assays exclusively. This expands ABL’s diagnostic footprint in Africa following recent acquisitions of PCR product rights and distribution collaborations including India.